MEVIS MEDICAL SOL.NA O.N.
MEVIS MEDICAL SOL.NA O.N./ DE000A0LBFE4 /
M3V/D
6/20/2025 5:36:12 PM
|
Chg.
0.000
|
Volume |
Bid6/20/2025 |
Ask6/20/2025 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
24.600EUR
|
0.00%
|
109 Turnover: 2,703.200 |
-Bid Size: - |
-Ask Size: - |
45.14 mill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
0.00 EUR |
- |
EPS Diluted: |
- EUR |
- |
Revenues per Share: |
9.53 EUR |
-7.57% |
Book Value per Share: |
9.79 EUR |
0.00% |
Cash Flow per Share: |
3.22 EUR |
20.53% |
Dividend per Share: |
- EUR |
- |
Total |
in mill. |
|
Revenues: |
17.34 EUR |
-7.57% |
Net Income: |
0.00 EUR |
- |
Operating Cash Flow: |
5.85 EUR |
- |
Cash and Cash Equivalents: |
7.74 EUR |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
- |
- |
P/S Ratio: |
2.60 |
2.62 |
P/BV ratio: |
2.53 |
2.55 |
P/CF Ratio: |
7.71 |
7.77 |
PEG: |
- |
- |
Earnings Yield: |
- |
0.00% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
45.14 mill. EUR |
45.5 mill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
395,929.8246 EUR |
399,122.8070 EUR |
Shares Outstanding: |
1.82 mill. |
|
Profitability
Gross Profit Margin: |
97.43% |
EBIT Margin: |
0.00% |
Net Profit Margin: |
0.00% |
Return on Equity: |
0.00% |
Return on Assets: |
0.00% |
Financial Strength
Liquidity I / Cash Ratio: |
- |
Liquidity II / Quick Ratio: |
- |
Liquidity III / Current Ratio: |
- |
Debt / Equity Ratio: |
57.37% |
Dynam. Debt / Equity Ratio: |
174.70% |
Efficiency
Employees: |
114 |
Personal Expenses / Employee: |
- EUR |
Revenues / Employee: |
152,114.04 EUR |
Net Income / Employee: |
0.00 EUR |
Total Assets / Employee: |
246,078.95 EUR |
* Fiscal Year End: |
9/30/2023 |